Friday, March 19, 2010: 7:00 AM-8:20 AM
Hanover E (Hyatt Regency Atlanta)
CME Credits: 1.25
Summary: This session will allow participants to hear updates on current strategies for pharmacologic and environmental aspects of HAI prevention in severely immunocompromised persons. Experts will also discuss the changing epidemiology of HAIs in this patient population.Learning Objectives:
- Identify challenges in surveillance for HAIs among immunocompromised patient populations.
- Apply knowledge about modifiable risk factors for and current strategies to prevent HAIs in this population.